The promoter-driven luciferase assay suggests the direct binding of WT1 to the Sox9 promoter in the presence of TGFα, which, consistent with the upregulation of Sox9 in the lung fibroblasts of IPF patients, is positively regulated by the TGFα-WT1 axis. Here, SOX9 is linked to idiopathic pulmonary fibrosis.